Listen now
Episode breakdown
Key takeaways
- Many cancer therapies carry a significant risk of damaging the heart, necessitating frequent cardiac screening throughout a patient's treatment.
- Skribe Medical's wearable monitoring platform aims to reduce treatment delays and improve patient convenience through a battery-free, AI-powered patch for cardiac function.
- Cybersecurity for connected medical devices must consider that hospital networks often pose greater challenges than home environments.
- Device manufacturers should integrate security considerations early in product development, especially as devices evolve toward connected healthcare technologies.
- The FDA's regulatory clearance is a significant milestone, but successful adoption of medical technology involves much more, including commercialization and reimbursement.
- The Predetermined Change Control Plan can address the challenges of evolving AI models in medical devices.
- Clinical testing and device validation are critical for the successful adoption of new medical technologies.
Cancer treatment is already difficult enough without adding more hospital visits, more testing, and more delays. Yet many cancer therapies carry a significant risk of damaging the heart, forcing patients to undergo regular cardiac screening throughout their treatment journey. What if clinicians could monitor cardiac function with a simple wearable patch instead?
In this episode of the Med Device Cyber Podcast, Christian Espinosa sits down with Ryan Neely, co-founder and CEO of Skribe Medical. Ryan shares his journey from neuroscience research and implantable neuroprosthetics to building a company focused on improving cardiac monitoring for cancer patients.
The discussion explores the growing field of cardio-oncology and the challenges patients face when cancer treatment depends on frequent cardiac assessments. Ryan explains how Skribe Medical's wearable monitoring platform aims to reduce treatment delays while improving patient convenience through a battery-free, AI-powered patch designed to measure cardiac function.
The conversation also takes a deep dive into cybersecurity considerations for connected medical devices. Ryan and Christian discuss common misconceptions about cybersecurity risk, why hospital networks often present greater challenges than home environments, and how device manufacturers should think about security as products evolve from standalone systems to connected healthcare technologies.
Finally, the episode explores commercialization, reimbursement models, FDA engagement, and the reality that regulatory clearance is often just one milestone in a much longer journey toward successful adoption.
Whether you're a MedTech founder, healthcare innovator, cybersecurity professional, or clinician, this episode offers valuable insights into the intersection of patient care, connected devices, and healthcare innovation.
Notable quotes
“What if clinicians could monitor cardiac function with a simple wearable patch instead?”
“Device manufacturers should think about security as products evolve from standalone systems to connected healthcare technologies.”
“Regulatory clearance is often just one milestone in a much longer journey toward successful adoption.”
“The realities of clinical testing and device validation are critical for product success.”
Frequently asked questions
Bring this work to your device
Need help with fda postmarket cybersecurity?
Blue Goat Cyber delivers fda postmarket cybersecurity services for medical device manufacturers - from threat modeling to FDA-ready reports.
FDA Postmarket Cybersecurity ServicesMore on FDA Postmarket Cybersecurity
Keep listening
-
Episode 49
How Cybersecurity Shapes Regulatory and Quality Success with Jim Goodmiller
With Jim Goodmiller
-
Episode 44
Cyber Risk Management for MedTech Legacy Devices
With MedTech leader
-
Episode 39
Medical Device Startups and Cybersecurity Challenges with Suzy Engwall
With Suzy Engwall
-
Episode 38
Top 10 Medical Device Vulnerabilities with Myles Kellerman
With Myles Kellerman